NNN
Niki BioSolutions, Inc.
No trades
No trades
Compare with Niki BioSolutions, Inc.
−1.36 M USD
0.00 USD
5.31 M
Profile
Sector
Industry
CEO
Ian Huen
Website
Headquarters
London
Founded
2010
ISIN
US6539421023
CUSIP
653942102
FIGI
BBG00LX0JFQ4
Identifiers
ISIN US6539421023
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of NIKI is 8.83 USD — it has decreased by −87.39% in the past 24 hours. Watch Niki BioSolutions, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Niki BioSolutions, Inc. stocks are traded under the ticker NIKI.
NIKI stock has fallen by −88.79% compared to the previous week, the month change is a −89.82% fall, over the last year Niki BioSolutions, Inc. has showed a −95.52% decrease.
NIKI stock is 898.57% volatile and has beta coefficient of 1.34. Track Niki BioSolutions, Inc. stock price on the chart and check out the list of the most volatile stocks — is Niki BioSolutions, Inc. there?
Yes, you can track Niki BioSolutions, Inc. financials in yearly and quarterly reports right on TradingView.
NIKI net income for the last quarter is −307.50 K USD, while the quarter before that showed −614.00 K USD of net income which accounts for 0.00% change. Track more Niki BioSolutions, Inc. financial stats to get the full picture.
No, NIKI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 21, 2026, the company has 2 employees. See our rating of the largest employees — is Niki BioSolutions, Inc. on this list?
Like other stocks, NIKI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Niki BioSolutions, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Niki BioSolutions, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Niki BioSolutions, Inc. stock shows the strong sell signal. See more of Niki BioSolutions, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.